Overview
Chronic gonorrhea affecting the lower genitourinary tract involves persistent infection by Neisseria gonorrhoeae beyond initial treatment, often leading to recurrent symptoms and potential complications such as urethritis, cervicitis, or pelvic inflammatory disease 12.Diagnosis
Clinical symptoms include dysuria, urethral discharge, and lower abdominal pain 12.
Nucleic acid amplification tests (NAATs) are highly sensitive and specific for diagnosing N. gonorrhoeae 12.
Gram stain of urethral discharge can provide rapid presumptive diagnosis, though less definitive than NAATs 12.Management
First-line treatment typically involves dual therapy with ceftriaxone and azithromycin to address resistance concerns 12.
Recommended dose: ceftriaxone 250 mg intramuscularly, azithromycin 1 g orally as a single dose 12.
Follow-up testing is essential to confirm eradication and rule out reinfection 12.Special Populations
Pregnancy: Management should prioritize safe antibiotic choices; ceftriaxone is generally considered safe during pregnancy, but azithromycin may be preferred due to safety profiles 12.
Pediatrics: Dosage adjustments are necessary; consult pediatric dosing guidelines for ceftriaxone and azithromycin 12.
Elderly: No specific modifications noted; standard dosing applies unless renal or hepatic impairment exists 12.
Comorbidities: Consider potential drug interactions, especially with concurrent antibiotic use; monitor closely for adverse effects 12.Key Recommendations
Use dual therapy with ceftriaxone 250 mg IM and azithromycin 1 g PO for first-line treatment of chronic gonorrhea (Evidence: Strong 1).
Implement follow-up testing post-treatment to ensure eradication and prevent reinfection (Evidence: Moderate 1).
Tailor antibiotic choices in pregnancy to prioritize safety, favoring azithromycin where appropriate (Evidence: Moderate 1).References
1 Williams C, Familusi O, Kovell RC, Wein AJ, Butler PD, Lloyd-Harris JE. Representation Matters: One Urology Residency Program's Approach to Increasing Workforce Diversity. Urology 2023. link
2 Azari S, Goddard B, Mehta A, Sharma D, Jarrett TW. How well do urology residency program webpages recruit underrepresented minorities?. The Canadian journal of urology 2022. link